Fidelity Investments’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Sell |
|
|||||
|
2025
Q1 | $346K | Sell |
|
|||||
|
2024
Q4 | $951K | Buy |
|
|||||
|
2024
Q3 | $1.65M | Buy |
|
|||||
|
2024
Q2 | $1.65M | Sell |
|
|||||
|
2024
Q1 | $2.74M | Sell |
|
|||||
|
2023
Q4 | $1.37M | Hold |
|
|||||
|
2023
Q3 | $1.35M | Sell |
|
|||||
|
2023
Q2 | $1.6M | Buy |
|
|||||
|
2023
Q1 | $1.72M | Hold |
|
|||||
|
2022
Q4 | $2.31M | Hold |
|
|||||
|
2022
Q3 | $1.7M | Hold |
|
|||||
|
2022
Q2 | $2.68M | Hold |
|
|||||
|
2022
Q1 | $3.25M | Hold |
|
|||||
|
2021
Q4 | $5.92M | Hold |
|
|||||
|
2021
Q3 | $8.16M | Sell |
|
|||||
|
2021
Q2 | $6.73M | Buy |
|
|||||
|
2021
Q1 | $8.38M | Hold |
|
|||||
|
2020
Q4 | $8.51M | Sell |
|
|||||
|
2020
Q3 | $20.1M | Hold |
|
|||||
|
2020
Q2 | $25.3M | Buy |
|
|||||
|
2020
Q1 | $4.29M | Hold |
|
|||||
|
2019
Q4 | $1.9M | Hold |
|
|||||
|
2019
Q3 | $2.38M | Hold |
|
|||||
|
2019
Q2 | $6.35M | Hold |
|
|||||
|
2019
Q1 | $6.79M | Hold |
|
|||||
|
2018
Q4 | $9.08M | Sell |
|
|||||
|
2018
Q3 | $30.4M | Sell |
|
|||||
|
2018
Q2 | $40.6M | Sell |
|
|||||
|
2018
Q1 | $43M | Sell |
|
|||||
|
2017
Q4 | $30.9M | Sell |
|
|||||
|
2017
Q3 | $40.7M | Sell |
|
|||||
|
2017
Q2 | $23.6M | Sell |
|
|||||
|
2017
Q1 | $34.6M | Sell |
|
|||||
|
2016
Q4 | $28.6M | Hold |
|
|||||
|
2016
Q3 | $49.8M | Hold |
|
|||||
|
2016
Q2 | $57.6M | Sell |
|
|||||
|
2016
Q1 | $57.5M | Buy |
|
|||||
|
2015
Q4 | $79.5M | Buy |
|
|||||
|
2015
Q3 | $57.7M | Sell |
|
|||||
|
2015
Q2 | $113M | Buy |
|